These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37331179)

  • 1. Clinical trial designs for evaluating and exploiting cancer evolution.
    Ingles Garces AH; Porta N; Graham TA; Banerji U
    Cancer Treat Rev; 2023 Jul; 118():102583. PubMed ID: 37331179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour heterogeneity in the clinic.
    Bedard PL; Hansen AR; Ratain MJ; Siu LL
    Nature; 2013 Sep; 501(7467):355-64. PubMed ID: 24048068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-Evaluating Clonal Dominance in Cancer Evolution.
    Burrell RA; Swanton C
    Trends Cancer; 2016 May; 2(5):263-276. PubMed ID: 28741512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting evolutionary steering to induce collateral drug sensitivity in cancer.
    Acar A; Nichol D; Fernandez-Mateos J; Cresswell GD; Barozzi I; Hong SP; Trahearn N; Spiteri I; Stubbs M; Burke R; Stewart A; Caravagna G; Werner B; Vlachogiannis G; Maley CC; Magnani L; Valeri N; Banerji U; Sottoriva A
    Nat Commun; 2020 Apr; 11(1):1923. PubMed ID: 32317663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of clonal evolution in multiple myeloma.
    Furukawa Y; Kikuchi J
    Int J Hematol; 2020 Apr; 111(4):496-511. PubMed ID: 32026210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases.
    Charles JP; Fuchs J; Hefter M; Vischedyk JB; Kleint M; Vogiatzi F; Schäfer JA; Nist A; Timofeev O; Wanzel M; Stiewe T
    Nat Commun; 2014 Jun; 5():3981. PubMed ID: 24889111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection.
    Niehr F; Eder T; Pilz T; Konschak R; Treue D; Klauschen F; Bockmayr M; Türkmen S; Jöhrens K; Budach V; Tinhofer I
    Clin Cancer Res; 2018 Jan; 24(1):158-168. PubMed ID: 29061642
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer - An Insurgency of Clones.
    Gisselsson D; Egnell R
    Trends Cancer; 2017 Feb; 3(2):73-75. PubMed ID: 28718446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution.
    Sepich-Poore GD; Guccione C; Laplane L; Pradeu T; Curtius K; Knight R
    Bioessays; 2022 May; 44(5):e2100252. PubMed ID: 35253252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Resistant Cancer Treatment Strategies Based on the Dynamics of Clonal Evolution and PKPD Modeling of Drug Combinations.
    Vakil V; Trappe W
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(3):1603-1614. PubMed ID: 33326383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and Chemotherapy-Induced Clonal Evolution of Tumors.
    Ibragimova MK; Tsyganov MM; Litviakov NV
    Biochemistry (Mosc); 2017 Apr; 82(4):413-425. PubMed ID: 28371598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics.
    Messerschmidt JL; Bhattacharya P; Messerschmidt GL
    Curr Oncol Rep; 2017 Aug; 19(10):66. PubMed ID: 28803390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal Evolution.
    Tang M; Zhao R; van de Velde H; Tross JG; Mitsiades C; Viselli S; Neuwirth R; Esseltine DL; Anderson K; Ghobrial IM; San Miguel JF; Richardson PG; Tomasson MH; Michor F
    Clin Cancer Res; 2016 Aug; 22(16):4206-4214. PubMed ID: 27006493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy.
    Chon YE; Jin B; Ahn SH; Kim S; Kim ND; Park JH; Nam CM; Kim KH; Hong SP; Choi SH; Kim DY; Park JY; Han KH
    Liver Int; 2015 Nov; 35(11):2370-83. PubMed ID: 25872678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal evolution models of tumor heterogeneity.
    Shlush LI; Hershkovitz D
    Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling.
    Scherer F
    Recent Results Cancer Res; 2020; 215():213-230. PubMed ID: 31605231
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.